(Q57396392)

English

Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure

scientific article published on 01 March 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Northridge DB

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Currie PF

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Newby DE

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Ford M

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Boon NA

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Dargie HJ

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

67-72

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

Inhibition of endopeptidase EC 24.11 in humans. Renal and endocrine effects

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

Effectiveness of endopeptidase inhibition (candoxatril) in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

Novel exercise protocol suitable for use on a treadmill or a bicycle ergometer

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

Atrial pressure and secretion of atrial natriuretic factor into the human central circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

Vasodilatory action of endogenous atrial natriuretic factor in a rat model of chronic heart failure as determined by monoclonal ANF antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

Inhibition of the metabolism of atrial natriuretic factor causes diuresis and natriuresis in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

Increased exercise capacity after digoxin administration in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

21 January 2018

Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiac and vascular effects of atrial natriuretic factor and sodium nitroprusside in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Sympathoinhibitory effects of atrial natriuretic factor in normal humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms involved in the response to prolonged infusion of atrial natriuretic factor in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of Neutral Endopeptidase (EC 3.4.24.11) Leads to An Atrial Natriuretic Factor-Mediated Natriuretic, Diuretic and Antihypertensive Response in Rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of UK 69 578: a novel atriopeptidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Candoxatril improves exercise capacity in patients with chronic heart failure receiving angiotensin converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2898%2900003-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1388-9842(98)00003-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10937982%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57396392&oldid=1933696203"